Advent Pharma Ltd. (DSE:ADVENT)

Market Cap	1.23B
Revenue (ttm)	517.69M
Net Income (ttm)	65.50M
Shares Out	93.13M
EPS (ttm)	0.71
PE Ratio	18.62
Forward PE	n/a
Dividend	0.05 (0.38%)
Ex-Dividend Date	Nov 23, 2025

Volume	271,508
Average Volume	107,284
Open	13.30
Previous Close	13.30
Day's Range	12.90 - 13.40
52-Week Range	11.50 - 17.30
Beta	0.37
RSI	48.91
Earnings Date	Jan 29, 2026

About Advent Pharma

Advent Pharma Ltd., a pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh. The company offers poultry, aquaculture, and cattle products. It provides its products in powder, bolus, and liquid dosage forms. It offers Yea-Sacc Bolus, Bioplex Dairy Max Bolus, SUPERIOR SYN BIOTECH, Oxi-D Bolus, and TOXOSORB. Advent Pharma Ltd. was incorporated in 2007 and is based in Dhaka, Bangladesh.

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 317
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ADVENT

Financial Performance

In 2025, Advent Pharma's revenue was 500.49 million, a decrease of -12.45% compared to the previous year's 571.67 million. Earnings were 66.87 million, a decrease of -20.38%.